Gossamer Bio, Inc. — Form D

Gossamer Bio, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-01. The offering totals $230.0M, of which $230.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Sheila Gujrathi, M.D.DirectorSan Diego, CA
Richard LimDirectorBOSTON, MA
Robert NelsenDirectorSeattle, WA
Otello Stampacchia, Ph.D.DirectorSan Diego, CA
Michael YiDirectorSouth San Francisco, CA
Sheila Gujrathi, M.D.Executive OfficerSan Diego, CA
Jill HoweExecutive OfficerSan Diego, CA
Kristina BurowDirectorSan Diego, CA
FAHEEM HASNAINDirectorSAN DIEGO, CA
FAHEEM HASNAINExecutive OfficerSAN DIEGO, CA
Sandra Milligan, M.D., J.D.DirectorSan Diego, CA
Russell CoxDirectorSan Diego, CA
Bryan GiraudoExecutive OfficerSan Diego, CA
Richard Aranda, M.D.Executive OfficerSan Diego, CA
Renee GalaDirectorSan Diego, CA
Caryn PetersonExecutive OfficerSan Diego, CA
Thomas Daniel, M.D.DirectorSan Diego, CA
Christian WaageExecutive OfficerSan Diego, CA
Laura Carter, Ph.D.Executive OfficerSan Diego, CA
Joshua Bilenker, M.D.DirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-08-07D$212.1M$212.1M
2022-07-18D$120.0M$120.0M
2018-01-19D$80.0M$70.5M
2018-01-19D$80.0M$70.5M

More